The International Journal of Biomedical Engineering and Technology, published by INDERSCIENCE ENTERPRISES LTD, serves as a pivotal platform for the dissemination of innovative research in the field of biomedical engineering. This journal, with ISSN 1752-6418 and E-ISSN 1752-6426, has been a valuable resource since its inception in 2007, boasting a converged publication timeline extending to 2024. Based in the United Kingdom, the journal aims to bridge the gap between engineering and biomedical sciences, facilitating interdisciplinary collaboration. As reflected in its 2023 Scopus ranking in the Q4 quartile of Biomedical Engineering, the journal remains accessible for researchers at various stages of their careers, contributing to its significance in promoting advancements in healthcare technologies. While currently not an open-access publication, the journal remains dedicated to enriching the biomedical engineering community by presenting novel research that addresses critical challenges, ultimately aiming to improve patient outcomes and drive innovation in medical devices and therapies.

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of biomedical materials science. With an ISSN of 0957-4530 and E-ISSN 1573-4838, this Open Access journal has been committed to providing researchers and professionals with freely accessible, high-quality research since 2021. It features an extensive scope spanning bioengineering, biomaterials, biomedical engineering, and biophysics, reflecting its significant impact within these interdisciplinary domains. Recognized within the Q2 category of the 2023 rankings in multiple fields, the journal proudly positions itself as a crucial resource for innovative materials that contribute to advancements in medical applications. With impressive Scopus rankings, including 26th in Biophysics and 40th in Materials Science for Biomaterials, researchers, students, and industry professionals alike can rely on this publication for cutting-edge insights that drive the future of medical materials and technologies. Based in Dordrecht, Netherlands, the journal provides a vibrant platform for sharing groundbreaking discoveries and fostering collaborative research among a global audience.

Elektronika Ir Elektrotechnika is a premier academic journal dedicated to the field of electrical and electronic engineering, published by Kaunas University of Technology, Lithuania. With an Open Access model since 2004, this journal ensures that cutting-edge research is accessible to a global audience, facilitating the dissemination of knowledge and fostering innovation in the engineering community. The journal is currently categorized in the Q3 quartile for Electrical and Electronic Engineering as of 2023 and holds a Scopus ranking of #473 out of 797, placing it in the 40th percentile. Covering a diverse range of topics from emerging technologies to foundational research, Elektronika Ir Elektrotechnika serves as an invaluable resource for researchers, professionals, and students alike, supporting the advancement of both theoretical and practical aspects in electrical engineering. As we converge towards the years 2008 to 2024, the journal invites submissions that contribute to the evolving landscape of the discipline, aiming to inspire future innovations and collaborations.

Physical and Engineering Sciences in Medicine is an esteemed peer-reviewed journal published by SPRINGER, dedicated to advancing the interdisciplinary fields of biomedical engineering and biophysics. With an ISSN of 2662-4729 and an E-ISSN of 2662-4737, this journal has carved a niche for itself since its inception in 2020. Situated in the Netherlands, it serves as a global platform for innovative research and developments that bridge the physical sciences and engineering with medical applications. The journal boasts a commendable range of quartile categorizations, highlighting its impact in various sectors including Instrumentation (Q1), Radiology (Q2), and Biotechnology (Q2). Its Scopus rankings further emphasize its relevance and quality, placing it in the top 15% in several categories. Being an Open Access title, it promotes the dissemination of knowledge, ensuring that vital research is accessible to all, thereby fostering collaboration among researchers, professionals, and students alike. The journal's objectives include promoting cutting-edge research, enhancing biomedical technology, and addressing complex health challenges through innovative engineering solutions, establishing it as a vital resource in the scientific community.

IRBM, published by Elsevier Science Inc, stands at the forefront of research in the domains of Biomedical Engineering and Biophysics, boasting impressively high rankings with a Q1 category in both fields according to the 2023 evaluations. With an effective focus on cutting-edge innovations and methodologies, IRBM provides a vital platform for researchers, professionals, and students alike seeking to disseminate and access groundbreaking findings and developments. Its strong presence in the Scopus database, with ranks of #12 in Biochemistry, Genetics and Molecular Biology and #42 in Biomedical Engineering, places it in the top percentile of impactful journals in the field, making it a crucial resource for advancing knowledge and fostering collaboration. While the journal maintains a traditional subscription model, it continues to attract a diverse readership eager for insightful studies and reviews that push the boundaries of science and engineering. With a projected convergence of years extending to 2024, IRBM promises to remain a significant contributor to the ongoing dialogue in the life sciences.

Annual Review of Biomedical Engineering, published by Annual Reviews, stands as a leading academic journal dedicated to the rapidly evolving field of biomedical engineering. With an impressive impact factor that reflects its high citation rates and rigorous peer-review process, this journal offers critical insights by synthesizing cutting-edge advancements and applications in both biomedical engineering and miscellaneous medicine. The journal, which is available in both print (ISSN: 1523-9829) and electronic formats (E-ISSN: 1545-4274), serves as an essential resource for researchers, professionals, and students aiming to stay abreast of significant developments and emerging trends. As of 2023, it is recognized in the top tier (Q1) for both Biomedical Engineering and Medicine, showcasing its esteemed position within the academic community, reflected in its high Scopus rankings. Spanning from 1999 to 2024, the Annual Review of Biomedical Engineering continues to catalyze interdisciplinary collaboration and innovation at the intersection of engineering and healthcare.

Bioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.

Cardiovascular Engineering and Technology, published by SPRINGER, stands as a prominent journal in the fields of Biomedical Engineering and Cardiology. With an ISSN of 1869-408X, this journal bridges the gap between engineering innovation and cardiovascular health by exploring the latest advancements pertinent to cardiovascular technologies and therapies. The journal, currently in its converged years from 2010 to 2024, holds important positions in Quartile 3 of both Biomedical Engineering and Cardiology and Cardiovascular Medicine categories, highlighting its relevance and influence in these domains. Ranked in the 59th percentile for Cardiology and 42nd percentile for Biomedical Engineering, the journal is a valuable resource for researchers, professionals, and students keen on understanding the intersection of engineering solutions and cardiovascular medicine. Although the journal is not open access, it remains highly regarded for its rigorous peer-reviewed content that contributes to the advancement of technology in the cardiovascular field.

BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS is a prominent journal dedicated to the dynamic field of biomedical engineering, published by WORLD SCIENTIFIC PUBL CO PTE LTD. Since its inception in 1992, the journal has provided a platform for the dissemination of high-quality research and innovative applications within the biomedical engineering domain. Despite its current Q4 ranking in multiple categories such as Bioengineering and Biomedical Engineering, the journal serves as an essential resource for researchers and professionals seeking to explore the latest developments and practical applications in this interdisciplinary field. The journal is based in Singapore, reflecting the region's growing influence in scientific research and technology. Although it does not offer open access, it continues to attract submissions that enrich the scientific dialogue within its community. With a commitment to fostering knowledge and research collaboration, this journal remains a vital contributor to the ongoing advancements in biomedical technology and engineering.

Advanced Biomedical Engineering is a peer-reviewed open access journal published by the Japanese Society for Medical & Biological Engineering, dedicated to disseminating high-quality research in the multidisciplinary fields of biomedical engineering. Boasting an ISSN of 2187-5219, this journal has been pivotal since its inception in 2018, especially as it embraces the open access model to foster knowledge sharing and wide accessibility. Centered in Tokyo, Japan, it serves as a vital platform for scholars and practitioners across various domains, such as biomaterials, biomedical engineering, and biotechnology. Despite currently residing in the Q4 quartile across several categories, including those in biotechnology and computer science applications, the journal is committed to elevating its academic impact and reputation, aiming for improved rankings in Scopus and other databases. Researchers and professionals are encouraged to contribute their innovative findings, discussions, and case studies, facilitating the advancement of this dynamic field.